We are conducting a research survey among patients diagnosed with Clostridium Difficile in London, UK. We would like to understand what it is like to have this condition, and your experience. We hope that this survey will create a better understanding of the condition with your opinions. You will be asked a few screening questions to assess if the topic of the survey is relevant to you.
We are conducting market research on various prevention drugs for medication, and we are looking for people from the United States to share their experience and views on specific prevention medications. Please note that we will not share any of your personal information as your answers are completely confidential. If you are interested to take part in this research, please click on the button below.
Fieldscope International is looking to speak to individuals from Wales, Scotland and Northern Ireland to participate in a market research study that aims to understand the experiences of people with diabetes or at risk of diabetes. We would like to get better insight on how you manage and care for your diabetes and how other aspects such as food, work and housing, affect your experiences of living with or being at risk of living with diabetes.
Nous menons une étude de marché sur les traitements d’oncologie orale et cherchons à parler aux patients masculins en oncologie qui ont de l’expérience avec les traitements d’oncologie orale. Le but de la recherche est d’explorer les moyens actuels d’augmenter l’observance de ces traitements et elle prendra la forme d’un sondage en ligne de 15 minutes. Pour participer à cette étude, veuillez cliquer sur le bouton ci-dessous.
This clinical trial aims to get better understanding of a possible treatment option for patients with non-small cell lung cancer (NSCLC). It includes an investigational treatment that is not approved for general use yet – before an investigational treatment can be approved, it needs to be studied in clinical trials like this one, so researchers and health authorities can understand how well it works, how safe it is and what are the side effects. The trial will include adult participants from multiple countries who have NSCLC and whose cancer cells have specific genetic mutations. These mutations affect the way the cancer cells grow and divide, as well as the way a person’s cancer responds to treatment. The trial is currently enrolling people whose tumors have a genetic mutation known as an “EGFR exon 20 insertion.”
Take a look at some of our most recent projects and apply.
We are conducting a research survey among patients diagnosed with Clostridium Difficile in London, UK. We would like to understand what it is like to have this condition, and your experience. We hope that this survey will create a better understanding of the condition with your opinions. You will be asked a few screening questions to assess if the topic of the survey is relevant to you.
We are conducting market research on various prevention drugs for medication, and we are looking for people from the United States to share their experience and views on specific prevention medications. Please note that we will not share any of your personal information as your answers are completely confidential. If you are interested to take part in this research, please click on the button below.
Fieldscope International is looking to speak to individuals from Wales, Scotland and Northern Ireland to participate in a market research study that aims to understand the experiences of people with diabetes or at risk of diabetes. We would like to get better insight on how you manage and care for your diabetes and how other aspects such as food, work and housing, affect your experiences of living with or being at risk of living with diabetes.
Nous menons une étude de marché sur les traitements d’oncologie orale et cherchons à parler aux patients masculins en oncologie qui ont de l’expérience avec les traitements d’oncologie orale. Le but de la recherche est d’explorer les moyens actuels d’augmenter l’observance de ces traitements et elle prendra la forme d’un sondage en ligne de 15 minutes. Pour participer à cette étude, veuillez cliquer sur le bouton ci-dessous.
This clinical trial aims to get better understanding of a possible treatment option for patients with non-small cell lung cancer (NSCLC). It includes an investigational treatment that is not approved for general use yet – before an investigational treatment can be approved, it needs to be studied in clinical trials like this one, so researchers and health authorities can understand how well it works, how safe it is and what are the side effects. The trial will include adult participants from multiple countries who have NSCLC and whose cancer cells have specific genetic mutations. These mutations affect the way the cancer cells grow and divide, as well as the way a person’s cancer responds to treatment. The trial is currently enrolling people whose tumors have a genetic mutation known as an “EGFR exon 20 insertion.”
Proud members and holders of:
